As previously reported, Raymond James downgraded Synovus (SNV) to Market Perform from Outperform with no price target The firm sees potential EPS downside risk given the company’s wide-ranging 2025 outlook and concern that shares could suffer from any re-emergence of industry credit fears, the analyst tells investors. The firm now views the risk-reward as balanced, but continue to view Synovus’ fundamental story positively given ongoing franchise investment and growth prospects in its “attractive Southeastern footprint,” the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV: